3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Keratosis, Actinic
6
Carcinoma, Basal Cell
4
Uterine Cervical Dysplasia
3
Squamous Intraepithelial Lesions
2
HIV Infections
2
Condylomata Acuminata
2
Precancerous Conditions
1
Patient Satisfaction
1
Papillomavirus Infections
1
Paget Disease, Extramammary
1
Hutchinson's Melanotic Freckle
1
Carcinoma, Squamous Cell
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Doxorubicin
6
Vincristine
4
Liposomes
4
Bleomycin
4
Fluorouracil
2
sargramostim
1
liposomal doxorubicin
1
Zidovudine
1
Watchful Waiting
1
Radiotherapy
1
Paclitaxel
1
Observation
1
Methotrexate
1
Light Coagulation
1
Leucovorin
1
Laser Therapy
1
Isotretinoin
1
Imiquimod
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Acquired Immunodeficiency Syndrome
×
Imiquimod
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts